SCHEMBL1733427

SCHEMBL1733427

COC(=O)Oc1nc(OC)c(NS(=O)(=O)c2cccc(Cl)c2Cl)nc1Cl

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1732229 0.90 CCR4 (0.77) CCR4
SCHEMBL1731557 0.86 CCR4 (0.78) CCR4
SCHEMBL1732170 0.84 CCR4 (0.76) CCR4
SCHEMBL13405429 0.83 CCR4 (0.74) CCR4
SCHEMBL1731353 0.83 CCR4 (0.74) CCR4
SCHEMBL1731984 0.82 CCR4 (1.00) CCR4
SCHEMBL1731590 0.82 CCR4 (0.72) CCR4
SCHEMBL1732747 0.82 CCR4 (0.72) CCR4
SCHEMBL1732907 0.82 CCR4 (0.69) CCR4
SCHEMBL1731893 0.81 CCR4 (0.71) CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467976-B1 N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES ASTRAZENECA AB (SE) 2011-11-23 EP claimed
WO-2011081310-A3 PEPTIDE MARKER FOR CANCER DIAGNOSIS, AND CANCER DIAGNOSIS METHOD USING SAME 한국기초과학지원연구원 (KR) 2011-10-27 WO claimed